Innovative Medicines Canada PMPRB Guidelines Webinar for Stakeholders

January 21, 2021
Innovative Medicines Canada

January 21, 2021 – You are invited to an update webinar on the amendments to the PMPRB Guidelines on Friday, January 29, from 12:00 noon to 1:00 p.m. (EST).   Mr. Steven Sampson, Senior Vice President, Health and Life Sciences, Global Public Affairs, will provide an update on the amendments to the PMPRB Guidelines resulting … Continue reading Innovative Medicines Canada PMPRB Guidelines Webinar for Stakeholders

MSFHR funds 19 innovators to advance made-in-BC health research and discoveries for improved patient care

January 21, 2021
Michael Smith Foundation for Health Research

January 21, 2021 – The 2020 Innovation to Commercialization and Health Professional-Investigator awardees are advancing health research towards practical applications, improving patient care, and developing made-in-BC technologies. We are British Columbia’s health research funding agency. Our programs are designed to develop, retain, and attract the people whose research improves the health of British Columbians, addresses … Continue reading MSFHR funds 19 innovators to advance made-in-BC health research and discoveries for improved patient care

InMed Pharmaceuticals to Participate in 2021 Cannabinoid-Derived Pharmaceuticals Industry Review Summit Europe

January 19, 2021
InMed Pharmaceuticals Inc.

Vancouver, BC – January 19, 2021 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (NASDAQ:INM) (TSX:IN), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the clinical development of cannabinol (“CBN”), today announced that executives of the Company will speak at the 2021 Cannabinoid-Derived Pharmaceuticals Industry Review Summit Europe … Continue reading InMed Pharmaceuticals to Participate in 2021 Cannabinoid-Derived Pharmaceuticals Industry Review Summit Europe

Testing Stream — Open calls for innovative prototypes

January 18, 2021
Government of Canada

January 18, 2021 – Innovative Solutions Canada has posted an Open Call today for innovative prototypes, which includes a Health stream under the standard component. The Testing Stream aims to procure, test and evaluate innovative late stage pre-commercial prototypes. The purpose of these calls for proposals (CFPs) is to create pools of pre-qualified innovations that Canada may … Continue reading Testing Stream — Open calls for innovative prototypes

ImmunoFlex™ Receives FLEX 10™ Product Approval From Health Canada

January 18, 2021
ImmunoFlex

VANCOUVER, BC, Jan. 18, 2021 /CNW/ – ImmunoFlex™, a life sciences company developing clinically validated, pharmaceutical grade natural health products based on advancements in genomics research, today announced the approval of FLEX 10™ by Health Canada. “At ImmunoFlex, we work with the immune system to strengthen, support, and enhance our body’s natural surveillance and response system.” said … Continue reading ImmunoFlex™ Receives FLEX 10™ Product Approval From Health Canada

entrepreneurship@UBC’s CORE and L2L Recruitment + Hiring in the US event coming up!

January 15, 2021
entrepreneurship@UBC

January 15, 2021 – Applications are live for our entrepreneurship@UBC CORE and Lab2Launch Venture Building Program! Applications are due February 25th. CORE is for ventures driving innovation through disruptive trends and technologies (think AI, consumer goods, retail, agritech, software, hardware etc) and Lab2Launch is for researchers looking to get their innovations from lab to market. We … Continue reading entrepreneurship@UBC’s CORE and L2L Recruitment + Hiring in the US event coming up!

MSFHR’s 2021 suite of funding opportunities will enable innovative health research across BC

January 14, 2021
Michael Smith Foundation for Health Research

January 14, 2021 – A new year brings a new suite of funding opportunities for BC’s health researchers. As BC’s health research funding agency, MSFHR is pleased to announce our 2021 funding competition lineup, reflecting rigorous program evaluation and direct input from BC’s health research community. Our funding programs are designed to attract, develop and … Continue reading MSFHR’s 2021 suite of funding opportunities will enable innovative health research across BC

Regulations Amending the Patented Medicines Regulations (PMPRB)

January 14, 2021

The Patented Medicine Prices Review Board (PMPRB) invites stakeholders to comment on two proposed consequential amendments to the new PMPRB Guidelines resulting from the decision to delay the coming-into-force date of the Regulations Amending the Patented Medicines Regulations (“Regulations”) a further six months, from January 1, 2021 to July 1, 2021.  The PMPRB proposes to … Continue reading Regulations Amending the Patented Medicines Regulations (PMPRB)

adMare Launches Abdera with AbCellera as a Founding Partner

January 14, 2021
adMare BioInnovations

January 14, 20201: adMare BioInnovations, Canada’s global life sciences venture, is pleased to announce the launch of Abdera Therapeutics Inc. (Abdera) with founding partner, AbCellera (Nasdaq: ABCL). Abdera is a precision oncology company developing novel next-generation targeted alpha therapies (TATs) for patients with relapsed, refractory and metastatic cancers. The seed financing of Abdera includes a … Continue reading adMare Launches Abdera with AbCellera as a Founding Partner

Xenon Pharmaceuticals Outlines Key Milestone Opportunities and Planned Leadership Transition in 2021

January 14, 2021
Xenon Pharmaceuticals Inc.

BURNABY, British Columbia, Jan. 14, 2021 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today outlined its key milestone opportunities and plans for a leadership transition in 2021, with all changes anticipated to take effect in June 2021 at the time of the Company’s annual meeting of shareholders. As part of the … Continue reading Xenon Pharmaceuticals Outlines Key Milestone Opportunities and Planned Leadership Transition in 2021